4.7 Article

Mitochondria and ubiquitin-proteasomal system interplay:: Relevance to Parkinson's disease

期刊

FREE RADICAL BIOLOGY AND MEDICINE
卷 45, 期 6, 页码 820-825

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2008.06.007

关键词

Parkinson's disease; MPP+; ubiquitin-proteasome system; mitochondria; reactive oxygen species; mitochondrial DNA-depleted cells

资金

  1. GAPI of Faculdade de Medicina da Universidade de Coimbra, Portugal
  2. Parkinson's Disease Foundation of the Heartland (USA)

向作者/读者索取更多资源

The cellular mechanisms that may underlie the death of dopaminergic neurons in Parkinson's disease are ubiquitin-proteasomal system (UPS) impairment, mitochondrial dysfunction. and oxidative stress. The goal of this work was to elucidate the correlation between mitochondrial dysfunction and UPS impairment, focusing Oil the role of oxidative stress. Our data revealed that mitochondria-DNA-depleted cells (rho 0) are compromised at the mitochondrial and UPS levels and also show an alteration of the oxidative status. In parental cells (rho+), MPP+ induced a clear inhibition of complex I activity, as well as an increase in ubiquitinylated protein levels, which was not observed in cells treated with lactacystin. Moreover, MPP+ induced a decreased in the 20S chymotrypsin-like and peptidyl-glutamyl peptide hydrolytic-like proteolytic activities after 24 h of exposure. RIDS Production Was increased in rho+ cells treated with MPP+ or lactacystin, at early treatment periods. MPP+ induced an increase in carbonyl group formation in rho+ cells. The results suggest that a mitochondrial alteration leads to an imbalance in the cellular oxidative status, inducing a proteasomal deregulation, which may exacerbate protein aggregation, and consequently degenerative events. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria

A. Raquel Esteves, Mario F. Munoz-Pinto, Daniela Nunes-Costa, Emanuel Candeias, Diana F. Silva, Joao D. Magalhaes, A. Raquel Pereira-Santos, I. Luisa Ferreira, Susana Alarico, Igor Tiago, Nuno Empadinhas, Sandra Morais Cardoso

Summary: This study aims to demonstrate that the effects of microbial toxin BMAA in the gut may trigger some cases of PD, and it can spread from the gut to the brain, leading to the development of PD. This finding is crucial for understanding the pathological progression of PD.
Review Microbiology

Enzyme Promiscuity in Serotonin Biosynthesis, From Bacteria to Plants and Humans

Sara Goncalves, Daniela Nunes-Costa, Sandra Morais Cardoso, Nuno Empadinhas, John David Marugg

Summary: Serotonin is a vital compound found in animals, plants, and bacteria. It plays critical roles in regulating body functions and its depletion is associated with neurological disorders in humans. Investigating the biosynthetic pathways of serotonin in bacteria, which may serve as a potential source of serotonin, could lead to important discoveries and the development of new therapeutic strategies.

FRONTIERS IN MICROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease

David Vicente-Zurdo, Noelia Rosales-Conrado, M. Eugenia Leon-Gonzalez, Leonardo Brunetti, Luca Piemontese, A. Raquel Pereira-Santos, Sandra M. Cardoso, Yolanda Madrid, Silvia Chaves, M. Amelia Santos

Summary: Alzheimer's disease (AD) is a serious and prevalent neurodegenerative disorder for which there is no cure. Recent research has focused on developing multi-target compounds for anti-AD drugs. In this study, seven novel RIV-BIM hybrids were developed and studied. These hybrids combine the active part of the drug rivastigmine with isomeric hydroxyphenylbenzimidazole units. The hybrids showed inhibition of cholinesterases, inhibition of amyloid beta-peptide aggregation, antioxidation, and metal chelation. They also demonstrated good capacity to promote cell viability and neuroprotection. Therefore, the RIV-BIM hybrids have the potential to be drug candidates for AD with multi-target abilities.

BIOMEDICINES (2022)

Review Neurosciences

Parkinson's Disease: A Multisystem Disorder

Helena Nunes Costa, Ana Raquel Esteves, Nuno Empadinhas, Sandra Morais Cardoso

Summary: The perception of sporadic Parkinson's disease has significantly changed in recent decades. It is now recognized as a multiorgan and multisystemic pathology that arises from the interaction of susceptible genetic factors with a challenging environment during aging-related decline.

NEUROSCIENCE BULLETIN (2023)

Article Neurosciences

Mitochondrial signaling on innate immunity activation in Parkinson disease

Joao D. Magalhaes, Sandra Morais Cardoso

Summary: Parkinson's disease (PD) is a neurodegenerative disease characterized by aSyn accumulation and neuro-inflammatory response. The mitocentric view suggests that mitochondrial dysfunction plays a crucial role in PD pathogenesis. Recent studies provide insights into the mitochondria-inflammation axis in PD etiology, although the mechanisms and effects of aSyn on mitochondrial and cellular dysfunction still need further investigation.

CURRENT OPINION IN NEUROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

The Role of Bacteria-Mitochondria Communication in the Activation of Neuronal Innate Immunity: Implications to Parkinson's Disease

Joao D. Magalhaes, Ana Raquel Esteves, Emanuel Candeias, Diana F. F. Silva, Nuno Empadinhas, Sandra Morais Cardoso

Summary: Mitochondria, which evolved from an endosymbiotic association, play a crucial role in regulating host metabolism, immunity, and cellular homeostasis. They share certain features with bacteria, known as mitochondrial-derived damage-associated molecular patterns (DAMPs), and their activities can be modulated by extracellular bacteria. In this study, it was found that mesencephalic neurons exposed to an environmental alphaproteobacterium activate innate immunity and show increased expression and aggregation of alpha-synuclein, which interacts with mitochondria, leading to dysfunction. These findings provide insights into the interaction between bacteria and neuronal mitochondria in triggering neuronal damage and neuroinflammation, and the role of bacterial-derived pathogen-associated molecular patterns (PAMPs) in Parkinson's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases

David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, Beatriz Guedes, Sandra M. Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, Silvia Chaves, M. Amelia Santos

Summary: A series of Rivastigmine-Benzimidazole (RIV-BIM) hybrids were found to have multitarget effects in combating Alzheimer's disease (AD). They exhibited antioxidant activity, acted as cholinesterase inhibitors, inhibited amyloid-beta aggregation, and chelated redox-active biometal ions. Furthermore, they showed remarkable inhibitory activity against monoamine oxidases and neuroprotective effects in human neuroblastoma cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson's Disease

Beatriz F. S. Guedes, Sandra Morais Cardoso, Ana Raquel Esteves

Summary: Parkinson's Disease (PD), the second most common neurodegenerative disorder, is characterized by severe loss of dopaminergic neurons and the presence of Lewy bodies. Non-motor symptoms, such as gastrointestinal dysfunction, may occur before motor symptoms. Studies have shown that gut microbiota, which is altered in PD patients, can influence the function of the nervous system. Altered expression of miRNAs, which regulate key mechanisms in PD, has also been observed in PD patients. The bidirectional interaction between gut microbiota and miRNAs may provide insights into the pathogenesis of gut-first PD and the development of biomarkers or therapeutic targets.

BIOMEDICINES (2023)

Article Cell Biology

Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer's disease

Daniela Marinho, Ildete Luisa Ferreira, Ricardo Lorenzoni, Sandra M. Cardoso, Isabel Santana, A. Cristina Rego

Summary: This study evaluates the efficacy of inhibiting or reducing histone deacetylases (HDACs) in Alzheimer's disease (AD) models by modifying gene transcription. The results show that inhibiting class I HDACs can ameliorate ER-mitochondria cross-talk in AD by normalizing calcium signaling between the two organelles. The selective HDAC inhibitor, Tacedinaline (Tac), counteracted the impaired ER-mitochondria communication and reduced amyloid beta levels in AD cells and animal models. These findings suggest that transcriptional regulation of ER-mitochondria communication could be a promising target for innovative therapeutics in AD.

AGING CELL (2023)

Article Biochemistry & Molecular Biology

LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease

A. Raquel Esteves, Diana F. Silva, Diogo Banha, Emanuel Candeias, Beatriz Guedes, Sandra M. Cardoso

Summary: Sporadic Parkinson's disease (sPD) is a complex multifactorial disorder with unknown etiology. Our study reveals that lipopolysaccharide (LPS)-induced activation of innate immunity requires functional mitochondria and mimics PD pathology in cells. We also demonstrate that a-synuclein overproduction is an innate immune response, and mitochondria play a crucial role in innate immunity activation in idiopathic PD.

REDOX BIOLOGY (2023)

Meeting Abstract Medicine, General & Internal

Gut microbiome-midbrain mitochondria axis in gut-first PD

S. M. Cardoso, N. Empadinhas

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Correction Biochemistry & Molecular Biology

miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease (vol 209, pg 292, 2023)

Siew Chin Chan, Chih-Wei Tung, Chia-Wei Lin, Yun-Shiuan Tung, Po-Min Wu, Pei-Hsun Cheng, Chuan-Mu Chen, Shang-Hsun Yang

FREE RADICAL BIOLOGY AND MEDICINE (2024)

Article Biochemistry & Molecular Biology

Ribosome-targeting antibiotic control NLRP3-mediated inflammation by inhibiting mitochondrial DNA synthesis

Suyuan Liu, Meiling Tan, Jiangxue Cai, Chenxuan Li, Miaoxin Yang, Xiaoxiao Sun, Bin He

Summary: This study reveals that the antibiotic doxycycline effectively inhibits NLRP3 inflammasome activation by targeting mitochondrial translation and mtDNA synthesis, offering potential for the treatment of NLRP3-related diseases.

FREE RADICAL BIOLOGY AND MEDICINE (2024)

Article Biochemistry & Molecular Biology

Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M

Hao Liu, Nana Li, Ge Kuang, Xia Gong, Ting Wang, Jun Hu, Hui Du, Minxuan Zhong, Jiashi Guo, Yao Xie, Yang Xiang, Shengwang Wu, Yiling Yuan, Xinru Yin, Jingyuan Wan, Ke Li

Summary: Protectin D1 (PTD1) improves hepatic steatosis, inflammation and fibrosis in a NASH mouse model by inhibiting the activation of TLR4 downstream signaling pathway, possibly through upregulation of IRAK-M expression, suggesting a potential new treatment for NASH.

FREE RADICAL BIOLOGY AND MEDICINE (2024)